期刊名称：HEALTH POLICY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Health Policy is intended to be a vehicle for the exploration and discussion of health policy issues and is aimed in particular at enhancing communications between health policy researchers, legislators, decision-makers, and other professionals concerned with implementing health policy. The journal encourages the submission of original, empirically based, comparative and/or global studies. In order to achieve the journal's objectives, authors are encouraged to write in a non-technical style which is understandable to health policy practitioners and specialists from other disciplines.
Instructions to Authors
Health Policy is intended to be a vehicle for the exploration and discussion of health policy issues and is aimed in particular at enhancing communication between health policy researchers, legislators, decision-makers and professionals concerned with developing, implementing, and analysing health policy.
The journal encourages the submission of original, empirically based, comparative and/or global studies. To achieve the journal's objectives, Authors are encouraged to write in a non-technical style, which is understandable to health policy practitioners and specialists from other disciplines.
Health Policy is affiliated with The International Society for Equity in Health and AcademyHealth.
Types of Contribution
Four types of articles are possible.
1. Research articles should report original research. The material should not have been previously published elsewhere.
2. Review articles should cover subjects, which are of current interest and which are within the scope of the journal. They may be submitted or invited.
3. A Second Opinion is a response to a paper recently published in the Journal. Second Opinions may be submitted or invited.
4. Letters to the Editor are welcome.
Health Policy is a truly international journal. Papers are invited from any country in the world. However, Authors should provide sufficient background and context, to ensure that their manuscript can be appreciated by an international readership.
Ethics in Publishing
For information on Ethics in Publishing and Ethical guidelines for journal publication see  http://www.elsevier.com/publishingethics and http://www.elsevier.com/ethicalguidelines.
Conflict of interest
All authors are requested to disclose any actual or potential conflict of interest including any financial, personal or other relationships with other people or organizations within three years of beginning the submitted work that could inappropriately influence, or be perceived to influence, their work. See also http://www.elsevier.com/conflictsofinterest.
Submission declaration
Submission of an article implies that the work described has not been published previously (except in the form of an abstract or as part of a published lecture or academic thesis), that it is not under consideration for publication elsewhere, that its publication is approved by all authors and tacitly or explicitly by the responsible authorities where the work was carried out, and that, if accepted, it will not be published elsewhere including electronically in the same form, in English or in any other language, without the written consent of the copyright-holder.
Copyright
Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright see http://www.elsevier.com/copyright). Acceptance of the agreement will ensure the widest possible dissemination of information. An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.
Subscribers may reproduce tables of contents or prepare lists of articles including abstracts for internal circulation within their institutions. Permission of the Publisher is required for resale or distribution outside the institution and for all other derivative works, including compilations and translations (please consult http://www.elsevier.com/permissions). If excerpts from other copyrighted works are included, the author(s) must obtain written permission from the copyright owners and credit the source(s) in the article. Elsevier has preprinted forms for use by authors in these cases: please consult http://www.elsevier.com/permissions.
Retained author rights
As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Role of the funding source
You are requested to identify who provided financial support for the conduct of the research and/or preparation of the article and to briefly describe the role of the sponsor(s), if any, in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication. If the funding source(s) had no such involvement then this should be stated. Please see http://www.elsevier.com/funding.
Funding body agreements and policies
Elsevier has established agreements and developed policies to allow authors whose articles appear in journals published by Elsevier, to comply with potential manuscript archiving requirements as specified as conditions of their grant awards. To learn more about existing agreements and policies please visit http://www.elsevier.com/fundingbodies.
Language and language services
Please write your text in good English (American or British usage is accepted, but not a mixture of these). Authors who require information about language editing and copyediting services pre- and post-submission please visit http://www.elsevier.com/languageediting or our customer support site at http://epsupport.elsevier.com for more information.
Submission
Submission to this journal proceeds totally online and you will be guided stepwise through the creation and uploading of your files. The system automatically converts source files to a single PDF file of the article, which is used in the peer-review process. Please note that even though manuscript source files are converted to PDF files at submission for the review process, these source files are needed for further processing after acceptance. All correspondence, including notification of the Editor's decision and requests for revision, takes place by e-mail removing the need for a paper trail.
Referees
Please submit, with the manuscript, the names, addresses and e-mail addresses of 3 potential referees. Note that the editor retains the sole right to decide whether or not the suggested reviewers are used.
Referee Process
Health Policy applies a double-blind review process, whereby the Authors are not revealed to the referees (and vice versa). Authors should very carefully follow the guidelines for preparing the manuscript to ensure anonymity in the electronic submission system. Authors should furthermore be aware that certain elements in the manuscript (e.g. referring to the own institution, or to own published work) may, unwillingly, reveal their identity to reviewers. It is the responsibility of the submitting Author to assure that all personal details are provided on a separate Title Page.
Revised version of the manuscript
On the basis of the comments of the referees and editors, Authors may be asked to revise their manuscript. In order to facilitate the evaluation of the revisions by the referees and editors, upon revision, Authors are asked: •to indicate all changes to the original manuscript by means of 'track changes' •to add a letter for the referees, explaining how they dealt with all of the recommendations and questions from the referees.
Authors should submit their revised version no later than 9 months after they were informed about the decision that the manuscript needs revision. If no revised manuscript is received 9 months after the decision, the manuscript will be considered as rejected.
Size and Layout
Manuscripts should be written in English. They should be clear, concise and logical.
Manuscripts should in principle be no longer than 4000 words, excluding references, figures and tables. Papers below this word limit are preferred. Exceptionally, if the topic requires a more extensive approach (e.g. review articles), manuscripts exceeding this word limit may be accepted.
Manuscripts should be structured as follows: •Title Page •Abstract •Introduction •Materials and methods •Results •Discussion •Conclusions •Acknowledgements (e.g. to sponsors) / conflicts of interest (when relevant) •References
Manuscripts should include a line count in order to facilitate the work of the referees.
Manuscripts that do not comply strictly with the above mentioned manuscript guidelines will be considered as non-admissible.
Essential title page information
• Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid abbreviations and formulae where possible.
• Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), please indicate this clearly. Present the authors' affiliation addresses (where the actual work was done) below the names. Indicate all affiliations with a lower-case superscript letter immediately after the author's name and in front of the appropriate address. Provide the full postal address of each affiliation, including the country name, and, if available, the e-mail address of each author.
• Corresponding author. Clearly indicate who will handle correspondence at all stages of refereeing and publication, also post-publication. Ensure that telephone and fax numbers (with country and area code) are provided in addition to the e-mail address and the complete postal address.
• Present/permanent address. If an author has moved since the work described in the article was done, or was visiting at the time, a "Present address" (or "Permanent address") may be indicated as a footnote to that author's name. The address at which the author actually did the work must be retained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.
Abstract
The abstract should not exceed 200 words and should be structured as follows: objectives, methods, results, conclusions. The abstract should not contain references to other published work. The abstract page should also include 3 to 6 keywords, using terms from the Medical Subject Headings from Index Medicus.
Figures, tables and equations
Figures and tables, and especially equations or other formulae should be kept to a minimum. Only those figures, tables and equations that are essential to clarify arguments in the manuscript should be included. Figures and tables should still be legible when reduced in size for printing.
Figures of good quality should be submitted online as a separate file. The lettering should be large enough to permit photographic reduction. The legend should be typed on a page separate from the figure. If there are multiple figures, the legends should be compiled together on one page (or more if necessary).
Tables should be submitted online as a separate file and should bear a short descriptive title. Legends for each table should appear on the same page as the table.
Throughout the manuscript text, Authors must indicate where approximately the tables and figures should be included.
Electronic artwork
General points
• Make sure you use uniform lettering and sizing of your original artwork.
• Save text in illustrations as "graphics" or enclose the font.
• Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.
• Number the illustrations according to their sequence in the text.
• Use a logical naming convention for your artwork files.
• Provide captions to illustrations separately.
• Produce images near to the desired size of the printed version.
• Submit each figure as a separate file.
A detailed guide on electronic artwork is available on our website:
http://www.elsevier.com/artworkinstructions
You are urged to visit this site; some excerpts from the detailed information are given here.
Formats
Regardless of the application used, when your electronic artwork is finalised, please "save as" or convert the images to one of the following formats (note the resolution requirements for line drawings, halftones, and line/halftone combinations given below):
EPS: Vector drawings. Embed the font or save the text as "graphics".
TIFF: color or grayscale photographs (halftones): always use a minimum of 300 dpi.
TIFF: Bitmapped line drawings: use a minimum of 1000 dpi.
TIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is required.
DOC, XLS or PPT: If your electronic artwork is created in any of these Microsoft Office applications please supply "as is".
Please do not:
• Supply embedded graphics in your wordprocessor (spreadsheet, presentation) document;
• Supply files that are optimised for screen use (like GIF, BMP, PICT, WPG); the resolution is too low;
• Supply files that are too low in resolution;
• Submit graphics that are disproportionately large for the content.
Literature references
Citation of literature references in the text should be done as numbers in square brackets. All references should be listed at the end of the paper on a separate page (also double spaced), arranged in numerical order of their appearance in the text, not in alphabetical order.
The Authors should ensure that there is a strict one-to-one correspondence between the names and years in the text and those on the reference list.
Examples: [1] Maynard A. Rationing health care: an exploration. Health Policy 1999;49:5-11.
[2] World Health Organization. The World Health Report 2000: improving health system performance. Geneva. 2001.
[3] Figueras J, Saltman RB, Busse R, Dubois FW. Patterns and performance in social health insurance systems. In: Saltman RB, Busse R, Figueras J, editors. Social health insurance systems in western Europe. Berkshire: Open University Press; 2004. p.81-140.
[4] Canadian Institute of Health Information. Health Care in Canada 2002, www.cihi.ca; 2002.
Appendices
Appendices should be avoided. If technical details on a study or analysis (e.g. questionnaires, models) are considered important for the review process, appendices can be included in the first submission. Final revisions should no longer include the appendices. Authors should then note that this additional material is available from the Authors upon request.
Submission checklist
It is hoped that this list will be useful during the final checking of an article prior to sending it to the journal's Editor for review. Please consult this Guide for Authors for further details of any item.
Ensure that the following items are present:
One Author designated as corresponding Author:
• E-mail address
• Full postal address
• Telephone and fax numbers
All necessary files have been uploaded
• Keywords
• All figure captions
• All tables (including title, description, footnotes)
Further considerations
• Manuscript has been "spellchecked" and "grammar-checked"
• References are in the correct format for this journal
• All references mentioned in the Reference list are cited in the text, and vice versa
• Permission has been obtained for use of copyrighted material from other sources (including the Web)
• Color figures are clearly marked as being intended for color reproduction on the Web (free of charge) and in print or to be reproduced in color on the Web (free of charge) and in black-and-white in print
• If only color on the Web is required, black and white versions of the figures are also supplied for printing purposes
For any further information please visit our customer support site at http://epsupport.elsevier.com.
Use of the Digital Object Identifier
The Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI consists of a unique alpha-numeric character string which is assigned to a document by the publisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is an ideal medium for citing a document, particularly 'Articles in press' because they have not yet received their full bibliographic information. The correct format for citing a DOI is shown as follows (example taken from a document in the journal Physics Letters B):
doi:10.1016/j.physletb.2003.10.071
When you use the DOI to create URL hyperlinks to documents on the web, they are guaranteed never to change.
Proofs
Proofs will be sent electronically to the Authors to be carefully checked for printer's errors. Changes or additions to the edited manuscript cannot be allowed at this stage . Corrected proofs should be returned to the publisher within 2 days of receipt.
Reprints
Twenty-five reprints will be supplied free of charge. The publisher will send Authors a form enabling further reprints to be ordered at prices listed on the form.
All questions arising after acceptance of the manuscript, especially those relating to proofs, should be directed to Elsevier Ireland Ltd., Elsevier House, Brookvale Plaza, East Park, Shannon, Co. Clare, Ireland, Tel: (+353) 61 709677; Fax: (+353) 61 709114.
Health Policy has no page charges.
For inquiries relating to the submission of articles (including electronic submission where available) please visit this journal's homepage. You can track accepted articles at http://www.elsevier.com/trackarticle and set up e-mail alerts to inform you of when an article's status has changed. Also accessible from here is information on copyright, frequently asked questions and more. Contact details for questions arising after acceptance of an article, especially those relating to proofs, will be provided by the publisher.
Editorial Board
Editorial Team:
Katrien Kesteloot
Leuven University, Center for Health Services and Nursing Research, Belgium, Email: heap@med.kuleuven.ac.be
Irina Cleemput
Belgian Health Care Knowledge Centre, Brussels, Belgium
Wija Oortwijn
Ecorys NL, Rotterdam, The Netherlands
Editorial Board
R.A. Atun
London, UK
K. Basu
Ontario, Canada
R.H. Brook
Santa Monica, CA, USA
K. Davis
New York, NY, USA
C. Donaldson
Newcastle-upon-Tyne, UK
M.F. Drummond
York, UK
J. Frenk
Mexico City, Mexico
L. Garattini
Ranica, Italy
S. De Geest
Basel, Switzerland
D. Hailey
Kambah, Australia
N. Homedes
Texas, USA
W. Hsiao
Boston, MA, USA
N. Ikegami
Tokyo, Japan
J.P. Kahan
Den Haag, The Netherlands
P. Kanavos
London, UK
M. Kelaher
Melbourne, Australia
G.M. Leung
Hong Kong
H.C. Lin
Taipei, Taiwan
D.H. Mariam
Addis Ababa, Ethiopia
A. Maynard
York, UK
D. McDaid
London, UK
G. Mooney
Perth, Australia
H. Nys
Leuven, Belgium
O. Onwujekwe
Nigeria
W. Oortwijn
Nijmegen, The Netherlands
J. Ovretveit
Gothenburg, Sweden
U.E. Reinhardt
Princeton, NJ, USA
E. Schokkaert
Leuven, Belgium
F.W. Schwartz
Hannover, Germany
A. Shmueli
Jerusalem, Israel
M. Young
Washington, DC, USA
|
